Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
- 16 December 1999
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 402 (S6763) , 43-47
- https://doi.org/10.1038/35005552
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJournal of Clinical Investigation, 1999
- Molecular biology of cartilage and bone destructionCurrent Opinion in Rheumatology, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Bone Mineral Density and Bone Metabolism in Diabetes MellitusHormone and Metabolic Research, 1997
- Paget's disease and osteoclast biologyBone, 1996
- ROLE OF CYTOKINES IN RHEUMATOID ARTHRITISAnnual Review of Immunology, 1996
- Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4Science, 1995
- Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor.The Journal of Experimental Medicine, 1995
- The importance of the t cell in initiating and maintaining the chronic synovitis of rheumatoid arthritisArthritis & Rheumatism, 1992
- RAG-1-deficient mice have no mature B and T lymphocytesCell, 1992